novoMEDLINK
US health care professionals can get Novo Nordisk product information, clinical education videos, product samples, patient education materials and formulary coverage data.
Request Product Samples From Novo Nordisk - novoMEDLINK
Launch the Novo Nordisk Sample Portal and if prompted, sign in with your novoMEDLINK™ account.
Diabetes education for your patients - novoMEDLINK
Our extensive library of diabetes educational materials is ready to download and share with your paitients, or order for complimentary delivery to your office. Topics include diabetes basics, making healthy meals, staying active, caring for a child with diabetes, and much more. Many are available in Spanish.
Diabetes Information and Education for Healthcare
Join experts: Dr John Anderson (primary care physician), Dr Pam Taub (cardiologist), and Dr Mark Greathouse (cardiologist) as they review the relationship between type 2 diabetes (T2D) and cardiovascular disease (CVD), including how T2D exacerbates CVD and the risk from CVD, and what the national medical associations recommend for patients with T2D and CVD.
Create Your Account - novoMEDLINK
novoMEDLINK™ is a trademark of Novo Nordisk A/S. Novo Nordisk is a registered trademark of Novo Nordisk A/S. Non-US Health Care Professionals, please go to www ...
Request Product Samples From Novo Nordisk - novoMEDLINK
Launch the Novo Nordisk Sample Portal and, if prompted, sign in with your novoMEDLINK™ account.
Diabetes Product Education for Patients | novoMEDLINK™
Ozempic ® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg For adult patients with type 2 diabetes (T2D), treated with diet and exercise to improve glycemic control, and to reduce the risk of major adverse cardiovascular events (cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke) in adults with T2D and established cardiovascular disease.
Diabetes Product Education for Professionals | novoMEDLINK™
Indications and Limitations of Use. Ozempic ® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus and to reduce the risk of major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, or nonfatal stroke) in adults with type 2 …
Diabetes Information and Pharmacy Resources - novoMEDLINK
Pharmacy personnel can access dosing and storage information on Novo Nordisk diabetes products and prescription savings card offers for eligible patients.
Diabetes Treatment Information for Health Care Professionals
Indications and Usage. Ozempic ® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes and to reduce the risk of major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, or nonfatal stroke) in adults with type 2 diabetes and established CV disease.